Abstract Details

Title Prognostic Significance of Neutralizing Antibodies, Binding Antibodies and MxA mRNA Measurements in Predicting Clinical Response in Patients with Multiple Sclerosis Treated with Interferon Beta

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 026

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Simona Malucchi	No disclosure on file
Francesca Gilli (Ospedale San Luigi)	No disclosure on file
Sana Syed, MD (Sanofi Genzyme)	Dr. Syed has received personal compensation for serving as an employee of Sanofi US.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Alessia Di Sapio, MD	No disclosure on file
	No disclosure on file
Marco Capobianco, MD	No disclosure on file
Antonio Bertolotto, MD, FAAN (Ospedale Koelliker)	Dr. Bertolotto has nothing to disclose.

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��